Vascularized Composite Allograft (VCA) Transplant - (0560) — MM 0560 | CIGNA Coverage Update

Cigna modified MM 0560 for vascularized composite allograft (VCA) transplantation, effective January 16, 2026. Here's what billing teams need to know.

Cigna Healthcare updated its coverage policy governing VCA transplantation under MM 0560 Cigna system. The five affected CPT codes — 21299, 21499, 22999, 26989, and 55899 — are all unlisted procedure codes classified as Experimental/Investigational/Unproven. If your practice or facility performs any VCA procedures and bills Cigna, this update directly affects how those claims get processed and whether reimbursement is possible.

Quick-Reference Table

Cigna VCA Transplant Coverage Criteria and Medical Necessity Requirements 2026

The Cigna VCA transplant coverage policy under MM 0560 takes a firm position: VCA transplantation does not meet Cigna's standard for medical necessity. The policy classifies VCA procedures as Experimental/Investigational/Unproven across all five applicable unlisted CPT codes.

VCA transplantation involves transplanting composite tissue structures — hands, faces, limbs, or other anatomical units — from a donor to a recipient. These are not organ transplants in the traditional sense. They involve vascularized soft tissue, bone, nerve, and skin as a composite unit. The clinical complexity is significant, and Cigna's position reflects its read of the current evidence base.

The coverage policy does not establish criteria under which VCA transplantation becomes covered. There are no medical necessity thresholds, no qualifying diagnoses, and no clinical conditions under which Cigna will approve these procedures as standard of care. The absence of a covered pathway matters for billing — there is no checklist to meet that unlocks reimbursement.

One important carve-out: uterine transplantation is explicitly excluded from MM 0560. Cigna routes uterine transplants to a separate coverage policy, "Infertility Services." If your practice performs or bills for uterine transplant procedures, do not look to MM 0560 for guidance. Go directly to Cigna's Infertility Services policy.

Prior authorization for these procedures will not resolve the coverage issue. When a payer classifies a service as Experimental/Investigational/Unproven, prior authorization is not a path to approval — it is a separate process that runs downstream of coverage determination. No prior auth will override an E/I/U designation under this coverage policy. Some billing teams confuse prior authorization denials with coverage denials. These are different. Under MM 0560, the issue is coverage, not auth.

Cigna VCA Transplant Exclusions and Non-Covered Indications

Every CPT code listed under MM 0560 carries the same classification: Experimental/Investigational/Unproven. There are no covered indications in this policy.

CPT 26989 covers unlisted procedures of the hands or fingers — the most common anatomical site for VCA transplantation (hand transplants). CPT 21299 covers unlisted craniofacial and maxillofacial procedures, which would capture face transplants. CPT 21499 applies to unlisted musculoskeletal procedures of the head. CPT 22999 covers unlisted abdomen musculoskeletal procedures. CPT 55899 applies to unlisted procedures of the male genital system — which would include penile transplantation.

All five codes fall under the same E/I/U umbrella. Cigna does not distinguish between transplant types or anatomical sites for coverage purposes. A hand transplant billed under CPT 26989 is treated the same as a face transplant billed under CPT 21299.

The real issue here is that these are all unlisted procedure codes. Unlisted codes require narrative descriptions and documentation submissions with every claim. When you combine an unlisted code with an E/I/U designation, you have two compounding denial risks. The claim will likely be denied for coverage reasons — but if documentation is incomplete, you may also get a technical denial on top of the substantive one. Keep those denial types separate in your tracking.

Coverage Indications at a Glance

Cigna VCA Transplant Billing Guidelines and Action Items 2026

These are steps your billing team should take now, ahead of the effective date of January 16, 2026.

If your facility performs VCA transplants on Cigna members and you're unsure how to handle patient financial counseling, charity care, or external funding sources, talk to your compliance officer and revenue cycle director now. This is not a billing problem with a billing solution — it's a coverage problem that needs a broader team response.

CPT, HCPCS, and ICD-10 Codes for VCA Transplantation Under MM 0560

The policy data for MM 0560 includes five CPT codes. No HCPCS Level II codes and no ICD-10-CM diagnosis codes are listed in this policy. All five CPT codes are classified as Experimental/Investigational/Unproven.

Not Covered / Experimental CPT Codes

A note on using unlisted codes: when you bill any of these CPT codes to Cigna, include a detailed operative report and a written narrative explaining the procedure. Unlisted codes require documentation to process. Under MM 0560, that documentation will not change the coverage outcome — but incomplete documentation adds a technical denial on top of the coverage denial, which complicates appeals.

There are no covered CPT codes under this policy. The policy does not list ICD-10-CM codes. Diagnosis codes for conditions that might lead to VCA transplant evaluation — such as traumatic amputation or severe facial disfigurement — do not affect coverage status under MM 0560.